Physician profile
Suril Patel
NPI 1639460686
$1,912.29
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $73.58 · 2022: $131 · 2023: $311 · 2024: $34.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $661.66 | 2019 | |
| Abbvie INC. | $535.84 | 2019-2024 | |
| Covidien LP | $287.98 | 2019 | |
| Olympus America INC. | $160.17 | 2019 | |
| Endogastric Solutions, INC | $145.47 | 2022-2023 | Esophyx |
| Lumendi LLC | $73.58 | 2020 | |
| Janssen Biotech, INC. | $18.66 | 2024 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.82 | 2023 | Xifaxan |
| Braintree Laboratories, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suril Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.